Association Between and End-stage Renal Disease: A Meta-analysis

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2017 Mar 16

PMID 28293097

Citations 11

Authors

Karn Wijarnpreecha

Charat Thongprayoon

Pitchaphon Nissaisorakarn

Natasorn Lekuthai

Veeravich Jaruvongvanich

Kiran Nakkala

Ridhmi Rajapakse

Wisit Cheungpasitporn

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the prevalence and association of () with end-stage renal disease (ESRD).

Methods: SA comprehensive literature search was completed from inception until October 2016. Studies that reported prevalence, relative risks, odd ratios, hazard ratios or standardized incidence ratio of among ESRD patients were included. Participants without were used as comparators to assess the association between infection and ESRD. Pooled risk ratios and 95%CI was calculated using a random-effect model. Adjusted point estimates from each study were combined by the generic inverse variance method of DerSimonian and Laird.

Results: Of 4546 relevant studies, thirty-seven observational studies met all inclusion criteria. Thirty-five cross-sectional studies were included in the analyses to assess the prevalence and association of with ESRD. The estimated prevalence of among ESRD patients was 44% (95%CI: 40%-49%). The pooled RR of in patients with ESRD was 0.77 (95%CI: 0.59-1.00) when compared with the patients without ESRD. Subgroup analysis showed significantly reduced risk of in adult ESRD patients with pooled RR of 0.71 (95%CI: 0.55-0.94). The data on the risk of ESRD in patients with were limited. Two cohort studies were included to assess the risk of ESRD in patients with . The pooled risk RR of ESRD in patients with was 0.61 (95%CI: 0.03-12.20).

Conclusion: The estimated prevalence of in ESRD patients is 44%. Our meta-analysis demonstrates a decreased risk of in adult ESRD patients.

Citing Articles

Gastrointestinal System Endoscopy and Pathological Findings in Non-Dialysis Chronic Kidney Disease: A Single-Center Study.

Usta M, Ersoy A, Ozer Sensoy N, Akgur S, Ozel M, Karaaslan Y Med Sci Monit. 2025; 31:e946516.

PMID: 40033672 PMC: 11889985. DOI: 10.12659/MSM.946516.

Appropriateness of Antiplatelet Therapy and Proton Pump Inhibitor Prescribing in End-Stage Kidney Disease: A Retrospective Quality Investigation Study.

Che M, Ahmed S, Chan R, Akbari A, Zimmerman D Can J Kidney Health Dis. 2025; 12:20543581241312618.

PMID: 39764378 PMC: 11701909. DOI: 10.1177/20543581241312618.

Determining the frequency of in children with chronic kidney failure and its relationship to gastrointestinal symptoms.

Nezhad B, Allahverdi B, Motamed F, Djalalinia S, Askarian F, Fahimi D Clin Case Rep. 2024; 12(7):e9157.

PMID: 38962467 PMC: 11220462. DOI: 10.1002/ccr3.9157.

A Retrospective Study from a Single Center in China to Develop a Nomogram to Predict One-Year Mortality in Patients with End-Stage Renal Disease Who Are Receiving Hemodialysis.

Yao W, Shen Y, Huang H, Yang H, Fang X, Shen L Med Sci Monit. 2022; 28:e936092.

PMID: 35850995 PMC: 9310550. DOI: 10.12659/MSM.936092.

Renal Dysfunction is an Independent Risk Factor for Rebleeding After Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding.

Ogiyama H, Tsutsui S, Murayama Y, Matsushima K, Maeda S, Satake S Turk J Gastroenterol. 2021; 32(8):622-630.

PMID: 34528875 PMC: 8975289. DOI: 10.5152/tjg.2021.20202.

References

Gur G, Boyacioglu S, Gul C, Turan M, Gursoy M, Baysal C . Impact of Helicobacter pylori infection on serum gastrin in haemodialysis patients. Nephrol Dial Transplant. 1999; 14(11):2688-91. DOI: 10.1093/ndt/14.11.2688. View

Gioe F, Cudia B, Romano G, Cocchiara G, Li Vecchi V, Gioe M . Role and clinical importance of Helicobacter pylori infection in hemodialysis patients. G Chir. 2008; 29(3):81-4. View

Nardone G, Rocco A, Fiorillo M, Del Pezzo M, Autiero G, Cuomo R . Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter. 2005; 10(1):53-8. DOI: 10.1111/j.1523-5378.2005.00291.x. View

Herzog R, Alvarez-Pasquin M, Diaz C, Del Barrio J, Estrada J, Gil A . Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013; 13:154. PMC: 3602084. DOI: 10.1186/1471-2458-13-154. View

Olmos J, Rosa Diez G, Higa R, Algranati S, Rios H, De Paula J . [Helicobacter pylori seroprevalence in dialysis patients]. Acta Gastroenterol Latinoam. 2004; 33(3):139-44. View

Krawczyk W, Gorna E, Suwala J, Rozyc P, Pawlowski L, Krzywicka A . Frequency of Helicobacter pylori infection in uremic hemodialyzed patients with antral gastritis. Nephron. 1996; 74(3):621-2. DOI: 10.1159/000189465. View

Khazaei M, Imanieh M, Al-Hashemi G . Gastrointestinal evaluation in pediatric kidney transplantation candidates. Iran J Kidney Dis. 2009; 2(1):40-5. View

Hsu W, Lin C, Lin C, Sung F, Hsu C, Kao C . The relationship between Helicobacter pylori and cancer risk. Eur J Intern Med. 2014; 25(3):235-40. DOI: 10.1016/j.ejim.2014.01.009. View

Blusiewicz K, Rydzewska G, Rydzewski A . Gastric juice ammonia and urea concentrations and their relation to gastric mucosa injury in patients maintained on chronic hemodialysis. Rocz Akad Med Bialymst. 2005; 50:188-92. View

10.

Davenport A, Shallcross T, Crabtree J, Davison A, Will E, Heatley R . Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron. 1991; 59(4):597-601. DOI: 10.1159/000186650. View

11.

Tsukada K, Miyazaki T, Katoh H, Yoshikawa M, Masuda N, Ojima H . Helicobacter pylori infection in hemodialysis patients. Hepatogastroenterology. 2003; 50(54):2255-8. View

12.

Onuigbo M . The CKD enigma with misleading statistics and myths about CKD, and conflicting ESRD and death rates in the literature: results of a 2008 U.S. population-based cross-sectional CKD outcomes analysis. Ren Fail. 2013; 35(3):338-43. DOI: 10.3109/0886022X.2013.764272. View

13.

Goni E, Franceschi F . Helicobacter pylori and extragastric diseases. Helicobacter. 2016; 21 Suppl 1:45-8. DOI: 10.1111/hel.12340. View

14.

Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y . Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2008; 75(1):96-103. PMC: 3126916. DOI: 10.1038/ki.2008.508. View

15.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

16.

Nakajima F, Sakaguchi M, Amemoto K, Oka H, Kubo M, Shibahara N . Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol. 2002; 22(5-6):468-72. DOI: 10.1159/000065278. View

17.

Offerhaus G, Kreuning J, Valentijn R, Pena A, Endtz P, van Duyn W . Campylobacter pylori: prevalence and significance in patients with chronic renal failure. Clin Nephrol. 1989; 32(5):239-41. View

18.

Chang W, Jo Y, Park H, Jegal J, Park J, Lee J . Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients. Clin Exp Nephrol. 2010; 14(5):469-73. DOI: 10.1007/s10157-010-0319-7. View

19.

Tamadon M, Saberi Far M, Soleimani A, Ghorbani R, Semnani V, Malek F . Evaluation of noninvasive tests for diagnosis of Helicobacter pylori infection in hemodialysis patients. J Nephropathol. 2014; 2(4):249-53. PMC: 3891128. DOI: 10.12860/JNP.2013.39. View

20.

Rauws E, Tytgat G . Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990; 335(8700):1233-5. DOI: 10.1016/0140-6736(90)91301-p. View